Respiratory Viral Infection Clinical Trial
Official title:
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recently received a hematopoietic cell transplant (HCT) or a solid organ transplant (SOT). Primary Objective To determine if pre-transplant screening for respiratory viral load predicts RVI within 1- year post-transplant among survivors. Secondary Objectives: - To develop and validate a classifier based on pre-transplant immunological profile predictive of developing an acute respiratory viral infection (aRVI), with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors. - To develop and validate a classifier based on Day +100 post-transplant immunological profiles predictive of developing an acute respiratory viral infection (aRVI),with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors .
The investigators will collect a nasal swab and blood sample from the participant when the participant is enrolled on the study and if the participant develops a RVI in the first year after transplant. The investigators will collect a blood sample 100 days after the participant's transplant. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04898023 -
Zinc and Green Tea Extract for Community Respiratory Viral Infections
|
Phase 2 | |
| Withdrawn |
NCT04842331 -
PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)
|
Phase 2/Phase 3 | |
| Completed |
NCT02260596 -
Respiratory Viral Infections in Pediatric Transplantation
|
N/A | |
| Not yet recruiting |
NCT06099873 -
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial of ZX-7101A Tablets to Evaluate the Efficacy and Safety in the Treatment of Uncomplicated Influenza in Adolescents
|
Phase 3 | |
| Completed |
NCT04898140 -
The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents
|
||
| Completed |
NCT04611061 -
Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers
|
||
| Not yet recruiting |
NCT05618483 -
Xylitol Based Nasal Spray for COVID-19 Treatment
|
N/A | |
| Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
| Terminated |
NCT04141917 -
Test-and-treat for Influenza in Homeless Shelters
|
Phase 4 | |
| Recruiting |
NCT06017310 -
Respiferon Project
|
||
| Enrolling by invitation |
NCT06188988 -
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
|
||
| Completed |
NCT04141930 -
Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle
|
Phase 4 | |
| Completed |
NCT05846360 -
The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer
|
||
| Completed |
NCT04532411 -
COVID-19 Testing Sample Acquisition Throughput and Efficiency
|
||
| Active, not recruiting |
NCT04258059 -
Wells and Enteric Disease Transmission Trial (WET - Trial)
|
N/A | |
| Active, not recruiting |
NCT04482673 -
Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
|
Phase 4 | |
| Not yet recruiting |
NCT05946538 -
Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics
|
N/A | |
| Recruiting |
NCT05092607 -
Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19
|
N/A | |
| Recruiting |
NCT05913700 -
Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
|
||
| Recruiting |
NCT04826991 -
Wells and Enteric Disease Transmission
|
N/A |